UCB S.A.
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 --
業務概覽 UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases. Historically, revenue was derived from allergy medicine Zyrtec and epilepsy drug Keppra, which have both lost patent protection. The firm's key products are Cimzia (immunology), Vimpat (epilepsy), Neupro (Parkinson's disease and restless leg syndrome), Briviact (epilepsy), Bimzelx (psoriasis), Evenity (osteoporosis), Nayzilam (cluster seizures), Fintepla (Dravet Syndrome and Lennox-Gastaut Syndrome), and Kygevvi (rare mitochondrial disease).
公司地址 Allee de la Recherche, 60, Brussels, BEL, B-1070
電話號碼 +32 25599999
傳真號碼 +32 25599900
公司網頁 https://www.ucb.com
員工數量 10117
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Jean-Christophe Tellier Director and Chief Executive Officer -- 25/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Ulf Wiinberg Independent Director 25/02/2026
Mr. Jonathan M. Peacock Chairman of the Board 25/02/2026
Mr. Jean-Christophe Tellier Director and Chief Executive Officer 25/02/2026
Dr. Jan Berger Independent Director 25/02/2026
Dr. Dolca Thomas, M.D. Independent Director 25/02/2026
Ms. Maelys Castella Independent Director 25/02/2026
Ms. Kay Davies Independent Director 25/02/2026
Mr. Pierre L. Gurdjian Independent Director 25/02/2026
Mr. Charles-Antoine Janssen Vice Chairman of the Board 25/02/2026
Mr. Stef Heylen Independent Director 25/02/2026
Mr. Cedric van Rijckevorsel Director 25/02/2026
Mr. Rodolfo J. Savitzky Independent Director 25/02/2026
Mr. Cyril Janssen Director 25/02/2026
Ms. Fiona Powrie Independent Director 25/02/2026
Ms. Nefertiti Greene Independent Director 25/02/2026
 
所屬ETF (更新日期: 07/03/2026 03:45)
代號 名稱 佔比% ▼ 持有日期
IGROiShares International Dividend Gr ETF0.002%28/02/2026
IQDGWisdomTree International Qual Div Gr ETF0.002%27/02/2026
EFAXState Street®SPDR®MSCIEAFEFsslFlRsvFrETF0.002%27/02/2026
JHMDJHancock Multifactor Developed Intl ETF0.002%27/02/2026
EFADProShares MSCI EAFE Dividend Growers0.002%27/02/2026
DIVIFranklin Intl Core Div Tlt Idx ETF0.001%28/02/2026
PABDiSharesParis-AlgndClmOptdMSCIWldexUSAETF0.001%28/02/2026
DOLWisdomTree True Developed Intl ETF0.001%27/02/2026
NTSIWisdomTree International Efficnt Cr ETF0.001%27/02/2026
LCTDiShares Wld ex USCrbTrnstnRdnssAwrActETF0.001%28/02/2026
PJIOPGIM Jennison International Opps ETF0.001%27/02/2026
MFDXPIMCO RAFI Dyn Multi-Factor Intl Eq ETF0.001%25/02/2026
DWMWisdomTree International Equity ETF0.001%27/02/2026
FEDMFlexShares ESG&Clmt Dev Mkts ex-US Cr0.001%27/02/2026
AVSDAvantis Responsible International Eq ETF0.001%28/02/2026
GXUSGoldman Sachs MarketBeta(R) Ttl IntEqETF0.001%24/02/2026
IQSINYLI Candriam International Equity ETF0.001%27/02/2026
EFAAInvesco MSCI EAFE Income Advantage ETF0.001%27/02/2026
JSTCAdasina Social Justice All Cp Glbl ETF0.001%27/02/2026
CRBNiShares Low Carbon Optd MSCI ACWI ETF0.001%28/02/2026
  1    2    3   4    5    6    7  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.